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ABSTRACT
Objective: Synthetic cationic antimicrobial peptide (SC-AMP) is an important and upcoming therapeutic molecule 
against conventional antibiotics. In this study, an attempt was made to purify the SC-AMP without the enzymatic cleav-
age of the affinity tag, by using an intein-based system.
Methods: The intein sequence was amplified from pTYB11 vector using PCR methodologies and the N-terminal of 
intein was ligated with SC-AMP. The designed construct, intein-SC-AMP was cloned into MCS region of cold shock 
expression vector, pCOLDI and the recombinant peptide was purified on a chitin affinity column by cleaving intein with 
50 mM DTT without applying enzymatic cleavage. Later the peptide was quantified and its antibacterial activity of the 
purified peptide was studied using well diffusion method.
Results: Initially, intein-SC-AMP was expressed as a fusion protein in both IPTG inducible E. coli BL21(DE3) and salt 
inducible E. coli GJ1158. Single step purification using CBD (chitin binding domain) - intein tag in salt inducible E. coli 
GJ1158, yields the SC-AMP in the soluble form at a concentration of 208 mg/L. The antibacterial activity and minimal 
inhibitory concentration (MIC) of the purified SC-AMP was studied against both Gram positive and Gram negative mi-
croorganisms.
Conclusion: For the first time, single step purification of soluble SC-AMP was carried out using chitin-binding domain 
affinity tag in salt inducible E. coli GJ1158 without an application of enzymatic cleavage. J Microbiol Infect Dis 2014;4(1): 
13-19
Key words: Synthetic cationic antimicrobial peptide, intein sequence, pCOLDI, chitin affinity column, E. coli BL21(DE3) 
and E. coli GJ1158.
Soğuk şok ekspresyon sistemi kaynaklı intein tabanlı katyonik antimikrobiyal peptitin tuz 
tarafından uyarılan E. coli GJ1158’den maliyet etkin şekilde saflaştırılması
ÖZET
Amaç: Sentetik katyonik antimikrobiyal peptid (SK-AMP) önemi gittikçe artan ve konvansiyonel antibiyotiklere alternatif 
olması beklenen terapötik bir moleküldür. Bu çalışmada SK-AMP’yi intein tabanlı bir sistem ile enzimatik parçalanma 
olmaksızın saflaştırmak amaçlanmıştır.
Yöntemler: İntein sekansı pTYB11 vektöründen PZR kullanılarak amplifiye edildi ve inteinin N-terminal ucu SK-AMP ile 
bağlandı. Oluşturulan bu yapı soğuk şok ekspresyon vektörü MCS bölgesine klonlandı. pCOLDI ve rekombinan peptid 
kitin afinite kodonundan 50 mM DDT ile ayrılarak enzimatik ayrıştırma olmaksızın toplandı. Daha sonra toplanan pepti-
tin miktarı belirlendi ve saflaştırılan pepitd yapının antimikrobiyal aktivitesi difüzyon yöntemi ile belirlendi.
Bulgular: Başlangıçta intein bağlı SK-AMP, IPTG indüklenebilir E. coli BL21(DE3) ve tuz indüklenebilir E. coli GJ1158’de 
bir füzyon protein olarak eksprese edildi. Tuz ile indüklenen E. coli GJ1158’de kitin bağlayan kodonun kullanıldığı tek 
basamaklı saflaştırma ile 208 mg/L konsantrasyonunda çözünebilir SK-AMP elde edildi. Saflaştırılmış SK-AMP’nin anti-
bakteriyel etkisi hem gram pozitif hem de gram negatif bakterilere karşı gösterildi ve minimum inhibitör konsantrasyonu 
belirlendi.
Sonuçlar: İlk kez çözünebilir SK-AMP tuz ile indüklenebilir E. coli GJ1158’den kitin bağlayan kodon kullanılarak tek ba-
samakta enzimatik ayrışma olmaksızın elde edildi.
Anahtar kelimeler: Sentetik katyonik antimikrobiyal peptid, intein sekansı, pCOLDI, kitin bağlayan kodon, E. coli BL21 
(DE3) ve E. coli GJ1158.JB Peravali, et al. Purification of intein based syntetic cationic antimicrobial peptide 14
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INTRODUCTION
Conventional antibiotics in general are produced 
by majority of molds and actinomycetes. Instead of 
regular antibiotics, new classes of antibiotics, pep-
tide antibiotics are encoded by the genes of various 
organisms.1-4 Peptide antibiotics are produced by 
lower vertebrates, various species of plants, insects 
and mammals. Approximately more than 575 pep-
tide antibiotics have been found up to date. Major-
ity of the peptide antibiotics are small length and 
cationic peptides with molecular weight less than 
5 kDa.5-7 Recently, different types of synthetic cat-
ionic peptide antibiotics have also been developed. 
These constructed synthetic cationic antimicro-
bial peptides contribute to the innate host defense 
against a number of harmful microbial pathogens, 
even some of the bacterial and fungal pathogens 
are resistant to conventional antibiotics. These syn-
thetic cationic peptide antibiotics target pathogenic 
microbial cellular membranes of different species 
of plants and animals.8 Some synthetic antimicro-
bial peptides have proved their activity remarkably 
even in animal models of infection against diverse 
pathogens viz., methicillin resistant Staphylococ-
cus aureus (MRSA) and malarial parasites.9-11 The 
important features like specific activity of SC-AMP 
without hemolytic activity hinder the resistance of 
microbes in infectious diseases and are useful in 
medical practice. Hence lot of research is going 
on the production of the peptide antibiotics as new 
class of therapeutics owing to their medical appli-
cations.12-14 On the other hand, enzymatic cleavage 
dramatically reduces the production range.
In our previous work, soluble form of synthetic 
cationic peptide antibiotics had been successfully 
expressed in E. coli and purified using 6X histidine 
tag  (data  not  shown  here).  Purification  using  6X 
histidine tag and enzymatic cleavage reduced the 
production yield. Based on its potentiality in medical 
microbiology, the heterologous expression and cost 
effective purification of synthetic cationic antimicro-
bial peptide has never been reported. In the present 
work, synthetic cationic antimicrobial peptide was 
expressed  efficiently  in  the  soluble  fraction  in  E. 
coli GJ1158 and intein tag was used as a fusion tag 
for one step purification, without enzymatic cleav-
age and quantity of the recombinant peptide was 
enhanced.
METHODS
Strains and plasmids
E. coli DH5α, E. coli BL21(DE3) and E. coli GJ1158 
were used in the present study. E. coli DH5α was 
used as the maintenance host and the remaining 
two cultures were used as expression hosts. The 
synthetic cationic antimicrobial peptide was con-
structed in our previous study (data not shown here). 
Plasmid pTYB11 was procured from New England 
Bio Labs and oligos were obtained from Sigma-Al-
drich, Bangalore. Plasmid pCOLDI was purchased 
from TAKARA Biosciences, Japan. E. coli GJ1158 
was provided by Genei, Bangalore, India. E. coli 
DH5α, E. coli BL21(DE3), Streptococcus pyogenes, 
Clostridium tetani, Listeria monocytogenes, Salmo-
nella enteric, Shigella dysenteriae, Staphylococcus 
aureus and Enterobacter aerogenes were procured 
from MTCC, Chandigarh, India.
Media preparation & culture conditions
Modified GYE medium (mGYEON) containing K2H-
PO4 - 6g/L, NaH2PO4 - 3 g/L, NH4Cl - 1 g/L, Yeast 
extract - 5 g/L, Glucose - 5g/L, 1M MgSO4 - 2 mL, 
TMM - 1 mL (CuSO4.H2O - 2 mg/L, Al2(SO4)3.7H2O 
- 10mg/L, H3BO4 - 1 mg/L, NiCl2.6H2O - 1 mg/L, 
MnCl3.4H2O  -  20  mg/L,  ZnSO4.7H2O  -  50  mg/L, 
Na2MoO4.2H2O - 50 mg/L, FeSO4 - 50 mg/L). After 
media sterilization, appropriate amount of ampicillin 
(100 µg/µl) was added at room temperature asepti-
cally. The initial pH of the medium was not adjusted 
to any value before autoclaving at 121°C for 15 to 
20 min at 15 lbps. NaCl was excluded from the me-
dia composition while working with E. coli GJ1158.
Isolation of intein and synthetic gene
The gene coding for the chitin binding domain - intein 
tag was amplified using pTYB11 with the following 
primers. Intein forward primer; 5’ CGCGGATCCT-
GCTTTGCCAAGGGTAC 3’ (26 mer; BamHI cleav-
age site is in bold) and intein reverse primer; 5’ 
CCCGAATCCGTTCTGTACAACAACCTG 3’ (27 
mer; EcoRI cleavage site is in bold). The synthetic 
cationic antimicrobial gene (78 bp) was amplified 
using the parental clone pPJB-KSR (pRSETA: syn-
thetic cationic antimicrobial peptide) by PCR with 
the following primers. SC-AMP forward primer; 5’ 
CGCGGATCCATGTGCCTTAAAGTC 3’ (24 mer; 
EcoRI cleavage site is in bold) and reverse primer; 
5’ GGGAAGCTTTTACATCTTGAACCAGAT 3’ (27 
mer; HindIII cleavage site is in bold)
The N-terminus of the intein was fused with 
the C-terminus of the gene (SC-AMP). On ligation, 
the construct was created with BamHI and HindIII 
at forward and reverse region for easy cloning into 
the multiple cloning site of highly expressible cold 
shock expression vector pCOLD I with T4 DNA li-
gase, followed by the transformation into mainte-
nance host DH5α.JB Peravali, et al. Purification of intein based syntetic cationic antimicrobial peptide 15
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Expression of intein-SC-AMP fusion protein
For  expression  studies,  the  recombinant  plasmid 
was transformed from maintenance host to salt 
inducible expression host E. coli GJ1158. The re-
combinant culture was grown at 37°C using glucose 
yeast extract medium (GYEON) in incubator shaker. 
When the OD600 reaches to 0.4 - 0.5 refrigerate the 
culture at 15°C and allow standing for 30 minutes. 
Later, sterile NaCl (at the final concentration of 200 
mM) was added aseptically and continue the incu-
bation on shaking at 15°C for 24 hours. After 24 hrs 
of induction, both uninduced and induced samples 
were pellet down, suspended in PBS (pH 8.0) and 
boil the samples at 100°C for 10 min. The protein 
analysis was carried out using 12% SDS-PAGE 
against a standard protein marker.
Purification of synthetic cationic antimicrobial 
peptide in E. coli GJ1158
The harvested E. coli GJ1158 cells were suspended 
in 100 mM Tris-HCl, 1 mM EDTA (pH 8.0) and 1 mM 
PMSF and mixed well. The sample was subjected 
to sonication of 5 cycles on time, 5 cycles off time 
and 5 min of total time. After sonication, the samples 
were centrifuged at 13,800 rpm for 10 min at 4°C. 
If any inclusion bodies are observed in the pellet, 
they are solubilized and refolded by using standard 
procedure for E. coli.15,16 
Inclusion bodies require solubilization using 
8M urea in 100 mM Tris-HCl buffer (pH 8.0). After 
solubilization, the total peptide is purified using af-
finity chromatography on chitin matrix. Initially, the 
soluble form of recombinant peptide was diluted 
to five times in TEN buffer (100 mM Tris-HCl [pH 
8.0], 1 mM EDTA [pH 8.0] and 500 mM NaCl; [pH 
8.0]) for optimal re-folding and efficient binding to 
the column. In the procedure, 10 ml chitin beads 
(New England Biolabs) were equilibrated with buf-
fer and the soluble refolded protein solution was 
loaded with a binding capacity of 2 mg/ml. The un-
bound proteins were removed by washing with 100 
mM Tris/HCl buffer containing 1 mM EDTA and 500 
mM NaCl (pH 8.0), followed by 50 mM DTT which 
induced on-column cleavage of synthetic cationic 
antimicrobial peptide from the intein tag at 4°C be-
tween 38 - 42 hrs in a static condition. The synthetic 
cationic antimicrobial peptide was eluted from the 
column using wash buffer. With the use of 2 kDa 
molecular weight cut off (MWCO) membrane, the 
DTT was removed gradually by dialysis using elut-
ed fractions (purified synthetic cationic antimicrobial 
peptide) against deionized water.
Biomass and wet cell weight was monitored 
at OD600. Peptide estimation was carried out using 
Lowry’s method17. Peptide analyses of the purified 
and unpurified samples were done using 18% Tri-
cine-SDS-PAGE.
Antimicrobial activity analysis
Antimicrobial activity of the desired peptide was 
checked by top agar assay and also by the well dif-
fusion method on pathogenic microorganisms such 
as Staphylococcus aureus and Enterobacter aero-
genes18. Initially bacteria was grown in appropriate 
broth (Luria-Bertani Broth) to an OD600 of 0.8 - 1.0. 
At OD600, 20 μL of both bacterial cultures was added 
to 8 mL of LB broth with 0.7 % agar and poured in 
petridish containing 25 mL of 1.5 % LB agar sepa-
rately. After the hardening of top agar, 10 μL of un-
purified  intein  SC-AMP  was  loaded  on  the  wells 
containing  Enterobacter aerogenes  and  6  μL  of 
purified synthetic cationic antimicrobial peptide was 
loaded on the wells containing Staphylococcus au-
reus and completely dried before incubating over-
night at 37°C. If sample has antimicrobial activity, a 
zone of inhibition was observed. PBS (Phosphate 
Buffer Saline) acts as negative control.
Determination of MIC
The  purified  peptide  was  further  analysed  for  its 
minimal inhibitory concentration on various bacte-
rial strains19. Different concentrations ranging from 
5 to 30 μg/ml of peptide (5 μg, 10 μg, 15 μg, 20 μg, 
25 μg and 30 μg/ml) was added to the optimal di-
luted pathogenic bacterial cultures (Streptococcus 
pyogenes,  Clostridium tetani,  Listeria monocyto-
genes, Salmonella enterica and Shigella dysenteri-
ae) incubated at 37°C for 3 hrs. After incubation, the 
five bacterial cultures were transferred and spread 
on agar plates and incubated at 37°C for overnight. 
The MIC of peptide concentration was recorded.
Hemolytic assay
The hemolytic activity of synthetic cationic antimi-
crobial peptide was determined with sheep eryth-
rocytes based on radial diffusion assay.20 The 
samples were loaded on well in the solidified blood 
agar medium and the 0.2% triton X-100 was used 
as positive control (hemolytically active). The plates 
were incubated at 37°C for overnight to determine 
the hemolytic activity of the peptide.
RESULTS
Construction of intein-SC-AMP expression plasmid
The Chitin Binding Domain-intein tag was amplified 
from T7 promoter based pTYB11 expression sys-
tem (Figure 1) and synthetic cationic antimicrobial JB Peravali, et al. Purification of intein based syntetic cationic antimicrobial peptide 16
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gene was also amplified (Figure 2). Later N and C 
terminus of intein and synthetic cationic antimicro-
bial gene was ligated and the desired construct is 
cloned in MCS region of BamHI and HindIII of highly 
expressible cold shock expression vector pCOLDI. 
The recombinant plasmid used for expression of 
synthetic cationic antimicrobial peptide as a fusion 
protein. Transformation of recombinant plasmid 
was carried out in the E. coli and the transformants 
were confirmed using colony lysate PCR and also 
by  sequencing  using  gene  specific  primers.  The 
sequence was 5’- CGCGGATCCATGTGCCTTA-
AAGTCCGTAT TTGGTTTAAAATGGAGGCGGAG-
GACATGTGCCTGAAGGTGCGCATCTGGTTCAA-
GATGAAGCTTCCC - 3’.
coli BL21(DE3) express the recombinant synthetic 
cationic antimicrobial peptide in inclusion body form 
at 37°C. The expression of 59.2 kDa fusion protein 
was confirmed using 12% SDS-PAGE (Figure 3).
Figure 3. 12% SDS-PAGE Analysis of recombinant pro-
tein (Intein SCAMP)
1: Uninduced culture of synthetic cationic antimicrobial 
peptide pCOLDI E. coli GJ1158
2, 3: Induced culture of synthetic cationic antimicrobial 
peptide pCOLDI E. coli GJ1158
M: Protein marker
Purification of recombinant peptide
Generally, recombinant peptides are expressed in 
soluble form. But negligible amount of peptide is ex-
pressed as insoluble aggregates in E. coli GJ1158. 
After  incubation,  protein  quantification  yields  the 
208 mg/L of recombinant peptide. The purified 2.9 
kDa peptide was confirmed using 18% Tricine-SDS-
PAGE is shown in Figure 4. The final yield of the 
purified recombinant peptide was less than around 
25% of the sample taken for purification.15
The recombinant peptide over expressed with 
salt inducible E. coli GJ1158 is comparatively less 
expensive than IPTG inducible BL21(DE3). The pu-
rification was easy due to the expression of peptide 
in soluble form using E. coli GJ1158, which has not 
been reported till to date using intein based single 
step purification.
Antimicrobial Activity
The antimicrobial activity was performed to deter-
mine the activity of unpurified intein synthetic cat-
ionic  antimicrobial  peptide  and  purified  synthetic 
cationic antimicrobial peptide. Fig. 5 shows the zone 
of clearance around the well containing recombi-
nant intein-SC-AMP, where control well shows no 
zone of inhibition. Fig. 6 shows the zone of clear-
ance around the well containing purified SC-AMP, 
where control well shows no zone of inhibition.
Figure 1.  Amplifica-
tion of intein
Lane 1: DNA Ladder; 
Lane 2: Intein ampli-
fication
Expression of recombinant synthetic cationic 
antimicrobial peptide in E. coli
Recombinant  E. coli expressing the intein - syn-
thetic cationic antimicrobial peptide was cultivated 
in mGYEON medium for cost effective production. 
The recombinant intein - synthetic cationic antimi-
crobial peptide was expressed in soluble form in-
stead of insoluble aggregates in E. coli GJ1158. 
Smith and Johnson (1988) have reported that lower 
temperatures remarkably improve the soluble re-
combinant expression21. On the other hand, E. 
Figure 2. Amplification 
of synthetic cationic 
antimicrobial gene
Lane 1: DNA Lad-
der; Lane 2: Synthetic 
cationic antimicrobial 
gene amplificationJB Peravali, et al. Purification of intein based syntetic cationic antimicrobial peptide 17
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Figure 4. 18% SDS-PAGE Analysis of synthetic cationic 
antimicrobial peptide
1: Purified synthetic cationic antimicrobial peptide (After 
second level)
2: Purified synthetic cationic antimicrobial peptide (First 
level)
M: Protein marker
MIC and hemolytic assay
The MICs of purified recombinant synthetic cationic 
antimicrobial peptide against Gram-positive and 
Gram-negative bacteria are shown in Table 1 and 
the MIC values in the range of 15-25 µg/ml. Some 
antimicrobial peptides exhibit hemolytic activities, 
but no hemolytic activity was observed even after 
overnight incubation using the concentration more 
than 30 μg/ml, indicating that SC-AMP was not toxic 
to red blood cells.
Table  1. Minimal inhibitory concentrations of synthetic 
cationic antimicrobial peptide on Gram positive and Gram 
negative microorganisms.
Pathogenic microorganisms
MICa (µg/ml)
of purified peptide
Gram positive
Streptococcus pyogenes
Clostridium tetani
Listeria monocytogenes
Staphylococcus aureus
25
15
20
25
Gram negative
Salmonella enterica
Shigella dysenteriae
Enterobacter aerogenes
25
20
10
a Experiments were carried out in triplicates
Figure 5. Activity analysis of in-
tein synthetic cationic antimicro-
bial peptide on Enterobacter aero-
genes
A: Negative control (PBS)
B: 10 µl of intein synthetic cationic 
antimicrobial peptide
Figure 6. Activity analysis of the 
purified  synthetic  cationic  anti-
microbial peptide on Staphylo-
coccus aureus
A: Negative control (PBS)
B: 6 µl purified synthetic cationic 
antimicrobial peptideJB Peravali, et al. Purification of intein based syntetic cationic antimicrobial peptide 18
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DISCUSSION
To look at the therapeutic potential of synthetic 
cationic antimicrobial peptide, soluble and cost ef-
fective production and purification is required. Ma-
jor drawback of recombinant peptides associated 
with difficulty in scale-up and observed low yields 
after purification.22-24 Multi-step purification reduces 
the yields to several folds and is not cost-effective. 
Using fusion his-tag thioredoxin, many AMPs have 
been expressed successfully in E. coli, but produc-
tion ranges are not satisfactory.25-27 In some stud-
ies, insoluble fractions are solubulized by using 
chaotropic detergent urea and guanidium hydro-
chloride. After refolding of the peptide using deter-
gents, peptides show less antimicrobial activity on 
pathogens, because of proteolytic degradation. Dif-
ferent enzymatic and chemical cleavage methods 
are employed to cleave a peptide from its fusion 
partner,  where  chemical  methods  are  inefficient. 
The N-terminal of the peptide is constructed with 
different proteases, such as thrombin, Factor Xa or 
enterokinase. In pCOLDI factor Xa is present at the 
upstream of the peptide. The presence of ten amino 
acids between factor Xa and peptide may have neg-
ative effect in terms of activity. The enzyme used 
to cleave the factor Xa is also expensive. Chen et 
al., in 2009 used the SUMO fusion system for cost 
effective antimicrobial peptide expression, but re-
moval of endotoxin was difficult.28
In some studies, peptides of varying lengths 
ranging from 37 amino acids for LL-37 to 9 amino 
acids for HHC-10 were produced 29. Li et al., in 2009 
achieved the expression and purification of peptides 
in the range of 30 amino acids and more.30 But after 
enzymatic cleavage and purification, the final yield 
was less than 10% of the sample taken for purifica-
tion. In this study, we produced 26 amino acid pep-
tide and the yield was less than ~25% of the sample 
taken for purification. Encouraging results of anti-
microbial activity using SC-AMP was studied with 
Gram positive and Gram negative microorganisms. 
The MIC of purified SC-AMP was also studied using 
Gram positive and Gram negative microorganisms. 
Among different Gram positive microorganism, 15 
µg/ml of purified SC-AMP was enough to inhibit the 
growth of Clostridium tetani and 25 µg/ml of puri-
fied SC-AMP was enough to inhibit the growth of 
Streptococcus pyogenes. But 10 µg/ml of purified 
SC-AMP was enough to inhibit the growth of En-
terobacter aerogenes. Hence this cost effective 
purification of synthetic cationic antimicrobial pep-
tide lacking enzymatic cleavage will have a huge 
demand in future if approved on clinical trials.
In conclusion, this study revealed the impor-
tance of single step purification of soluble recom-
binant synthetic cationic antimicrobial peptide from 
salt inducible E. coli GJ1158 using intein with a 
chitin binding domain affinity tag. The main advan-
tage is expressing the soluble recombinant peptide 
without enzymatic cleavage and increasing peptide 
quantity.
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